Kymera Therapeutics Inc (KYMR)
EBITDA
-$291.43M
TTM · Period ending: · USD
KYMR EBITDA
Latest reported-$291.43Mperiod ending
Latest reported-$291.43Mperiod ending
KYMR TTM EBITDA (-$43.72M → -$291.43M)
TTM EBITDA
High-resolution chart · PNG
KYMR ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| -291,429,000 | |
| -306,751,000 | |
| -303,061,000 | |
| -286,615,000 | |
| -267,029,000 | |
| -232,670,000 | |
| -216,236,000 | |
| -160,955,000 | |
| -152,446,000 | |
| -150,234,000 | |
| -143,201,000 | |
| -163,765,000 | |
| -154,033,000 | |
| -155,693,000 | |
| -151,655,000 | |
| -150,828,000 | |
| -136,470,000 | |
| -121,039,000 | |
| -97,649,000 | |
| -76,648,000 | |
| -56,275,000 | |
| -45,770,000 | |
| -43,715,000 | |
| -42,676,000 | |
| -46,466,000 |